|
12/26/2006--
Columbia Laboratories Closes $40
Million Private Placement Of Convertible Subordinated Notes And Completes
Acquisition Of U.S. Marketing Rights To Crinone® Progesterone Gel
12/22/2006--
Columbia Laboratories Completes
Treatment Phase Of Phase III Study Of Prochieve 8% To Prevent Recurrent Preterm
Birth
12/22/2006--
Columbia Laboratories To Raise $40
Million Through Private Placement Of Convertible Subordinated Notes
12/07/2006--
James Meer Appointed Chief Financial
Officer Of Columbia Laboratories
11/09/2006--
Columbia Laboratories Reports Third
Quarter 2006 Financial Results
11/07/2006--
Columbia Laboratories Advances
Clinical Development of Lidocaine Candidate
10/26/2006--
Columbia Laboratories to Present at
Rodman & Renshaw Healthcare Conference in NYC
10/23/2006--
Columbia Laboratories Comments on FDA
Decision on Adeza’s Gestiva
10/23/2006--
Columbia Laboratories to Discuss
Third Quarter 2006 Financial Results on November 9, 2006
08/29/2006--
Columbia Laboratories Comments on FDA
Reproductive Drugs Advisory Committee Recommendation on 17-OHPC
08/09/2006 --
Columbia Laboratories Reports Second
Quarter 2006 Financial Results
08/07/2006 --
Columbia Laboratories to Present at
Roth Capital Partners Equity Conference in NYC on September 6, 2006
08/01/2006 --
Columbia Labs Completes Enrollment in
Pivotal Phase III Study of Prochieve 8% to Prevent Preterm Birth
07/31/2006 --
Columbia Laboratories to Discuss 2Q
2006 Financial Results on August 9, 2006 Conference Call
06/01/2006 --
Columbia Laboratories to Present at
FTN Midwest Securities Health Care Conference in NYC
05/15/2006 --
Columbia Laboratories Added To NASDAQ
Biotechnology Index
05/09/2006 --
Columbia Laboratories Reports First
Quarter 2006 Financial Results
05/02/2006 --
Columbia Laboratories to Discuss First
Quarter 2006 Financial Results on May 9, 2006 Conference Call
03/14/2006 --
Columbia Laboratories closes $30
Million Private Placement
03/13/2006 --
Columbia Laboratories To Raise $30
Million Through Private Placement Of Common Stock And Warrants
03/07/2006 --
Columbia Laboratories Reports Fourth
Quarter and Year-End 2005 Financial Results
03/07/2006 --
Robert S. Mills Elected Chief
Executive Officer of Columbia Laboratories
02/24/2006 --
Columbia Laboratories to Discuss
Fourth Quarter and Year End 2005 Financial Conference Call
01/09/2006 --
Columbia Laboratories announces
management changes
|